NO127535B - - Google Patents
Download PDFInfo
- Publication number
- NO127535B NO127535B NO101/69A NO10169A NO127535B NO 127535 B NO127535 B NO 127535B NO 101/69 A NO101/69 A NO 101/69A NO 10169 A NO10169 A NO 10169A NO 127535 B NO127535 B NO 127535B
- Authority
- NO
- Norway
- Prior art keywords
- methylene
- dione
- hydroxy
- pregnene
- epoxy
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000001589 carboacyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- -1 acetyl compound Chemical class 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Chemical group 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 231100000546 inhibition of ovulation Toxicity 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000757 progestagenic effect Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ARUYPSAYKHCXNE-UQNNAPNASA-N 2701-50-0 Chemical compound C1=CC2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 ARUYPSAYKHCXNE-UQNNAPNASA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 1
- 206010063146 Uterine hypoplasia Diseases 0.000 description 1
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 230000003152 gestagenic effect Effects 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960001712 testosterone propionate Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1967SC040469 DE1643017B2 (de) | 1967-03-31 | 1967-03-31 | Verfahren zur herstellung von 6-chlor-1,2alpha-methylen-delta hoch 4,6-pregnadienen |
| DESC041823 | 1968-01-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO127535B true NO127535B (xx) | 1973-07-09 |
Family
ID=25993457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO101/69A NO127535B (xx) | 1967-03-31 | 1969-01-10 |
Country Status (10)
| Country | Link |
|---|---|
| AT (2) | AT279818B (xx) |
| BE (1) | BE712938A (xx) |
| CH (2) | CH564039A5 (xx) |
| DE (2) | DE1643017B2 (xx) |
| DK (2) | DK116941B (xx) |
| FR (2) | FR1579547A (xx) |
| GB (1) | GB1229428A (xx) |
| NL (2) | NL155020B (xx) |
| NO (1) | NO127535B (xx) |
| SE (2) | SE343056B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH545777A (xx) * | 1971-02-05 | 1974-02-15 |
-
1967
- 1967-03-31 DE DE1967SC040469 patent/DE1643017B2/de active Granted
-
1968
- 1968-01-11 DE DE19681668685 patent/DE1668685C3/de not_active Expired
- 1968-02-26 DK DK75068A patent/DK116941B/da not_active IP Right Cessation
- 1968-03-06 AT AT220568A patent/AT279818B/de not_active IP Right Cessation
- 1968-03-12 AT AT244668A patent/AT301038B/de not_active IP Right Cessation
- 1968-03-22 DK DK126368A patent/DK116208B/da unknown
- 1968-03-26 CH CH450768A patent/CH564039A5/xx not_active IP Right Cessation
- 1968-03-27 CH CH451568A patent/CH548382A/xx not_active IP Right Cessation
- 1968-03-28 NL NL686804395A patent/NL155020B/xx unknown
- 1968-03-28 NL NL6804394A patent/NL156706B/xx not_active IP Right Cessation
- 1968-03-29 SE SE422068A patent/SE343056B/xx unknown
- 1968-03-29 BE BE712938D patent/BE712938A/xx unknown
- 1968-03-29 FR FR1579547D patent/FR1579547A/fr not_active Expired
- 1968-03-29 SE SE422168A patent/SE331839B/xx unknown
- 1968-04-01 GB GB1229428D patent/GB1229428A/en not_active Expired
- 1968-06-27 FR FR156884A patent/FR7900M/fr not_active Expired
-
1969
- 1969-01-10 NO NO101/69A patent/NO127535B/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL156706B (nl) | 1978-05-16 |
| CH548382A (de) | 1974-04-30 |
| BE712938A (xx) | 1968-09-30 |
| SE331839B (xx) | 1971-01-18 |
| GB1229428A (xx) | 1971-04-21 |
| AT279818B (de) | 1970-03-25 |
| DE1643017A1 (de) | 1971-04-15 |
| DE1668685B2 (de) | 1974-08-29 |
| DE1643017B2 (de) | 1976-09-09 |
| DE1668685A1 (de) | 1971-10-07 |
| FR7900M (xx) | 1970-05-11 |
| NL6804395A (xx) | 1968-10-01 |
| AT301038B (de) | 1972-08-25 |
| DE1668685C3 (de) | 1975-04-24 |
| NL155020B (nl) | 1977-11-15 |
| DK116941B (da) | 1970-03-02 |
| NL6804394A (xx) | 1968-10-01 |
| CH564039A5 (xx) | 1975-07-15 |
| SE343056B (xx) | 1972-02-28 |
| FR1579547A (xx) | 1969-08-29 |
| DK116208B (da) | 1969-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3296255A (en) | 2-cyano steroids | |
| US3965128A (en) | 6β,7β-Epoxy-1α,2α-methylen-D-homo-4-pregnen-3,20-diones | |
| US3318926A (en) | 7alpha-methyl-16alpha-hydroxy-estrones | |
| US3682983A (en) | Preparation of {66 {11 {11 -17 ethinyl steroids | |
| JPS5931800A (ja) | １９−チオ−アンドロスタン誘導体 | |
| US3385871A (en) | Halogenated cyclopropyl and cyclopropenyl estratrienes and process for their preparation | |
| US3812166A (en) | Dichloro-substituted estradiene | |
| US3576828A (en) | Delta**4,9,11-trienes of the 19-nor-androstene series and process for their manufacture | |
| US3980638A (en) | Testosterone derivatives | |
| US3492338A (en) | D-homosteroids and process for their preparation | |
| NO127535B (xx) | ||
| US3509135A (en) | 3-oxygenated 4'-5 - dihydrospiro(estra-4,9-diene-17,2'(3'h)-furans) and congeners | |
| US3470216A (en) | Selected 17,17-difluoro unsaturated androstanes | |
| US3706737A (en) | Novel 5beta,19-(epoxyethanoimino)-steroids | |
| US3151134A (en) | Delta9(11)-dehydro-estrone, estradiol, derivatives thereof and process for preparation | |
| US3373157A (en) | 6, 6-ethylene-19 nortestosterones | |
| US3252930A (en) | Intermediates in the synthesis of 1alpha-hydroxy-3-ketosteroids | |
| US3102897A (en) | 6-halo-19-nor-delta4,6-androstadien-17beta-ol-3-one derivatives | |
| US3377342A (en) | 2', 2'-bistrifluoromethyloxetano(3', 4'; 16alpha, 17alpha)derivatives of 4-pregneno [3, 2-c]pyrazoles and 4, 6-pregnadieno [3, 2-c]pyrazoles | |
| US3574690A (en) | Delta 4,9,11-gonatriene-3-ones | |
| US3789087A (en) | 4,6-dichlor- {66 {11 {11 {11 -steroids and method of making and using the same | |
| US3644441A (en) | Method for the production of 21-fluoro-4 6-pregnadienes | |
| US3584016A (en) | 18-methylene-steroids of the pregnane series | |
| US3153061A (en) | 17-substituted 2, 5-pregnadiene derivatives | |
| NO135527B (xx) |